The Flow Cytometry Service provides Cancer Center researchers with access to state-of-the-art flow cytometric equipment including a Becton-Dickinson (BD) FACStar cell sorter, a single-laser BD FACScan analyzer, and a dual-laser BD FACSCalibur analyzer. Service personnel have extensive expertise in current cytometric applications and also manage and distribute customized reagents from the Service's monoclonal antibody resource. Flow Cytometry is operated on a first-come, first-served basis offering services through either assisted or unassisted access. Through assisted access, Flow Cytometry staff offers preparation of cells, nuclei, or chromosomes for analysis or sorting on the appropriate flow cytometer. As part of this service, Cancer Center staff and the experienced technical staff of the Service develop a protocol that is then carried out by the Flow Cytometry staff. Upon completion of the experiment, the technicians are available to assist with data analysis in association with the researcher. The Service also assists researchers with the design of protocols using a variety of existing and newly developed dye compounds, and in parallel the Service offers custom reagent preparation employing these dyes. Through unassisted access, trained users independently acquire and analyze data as needed with Service's technical support available at all times. Flow Cytometry has been supported by the Cancer Center support grant for 18 years, and is an integral component of research at the Cancer Center. Use of this Service has increased 23 percent since the first year of the current CCSG funding period. To meet the increased user demand and operate additional cytometry instrumentation, additional technical labor was added during the current five-year CCSG period. Derry C. Roopenian, Ph.D., an immunologist, has served as the Scientific Staff Supervisor since 1991. Dr. Roopenian communicates regularly with the User Group and service personnel to insure that users have equitable service access and that their needs are met in the most efficient, cost effective and technically current manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA034196-20
Application #
6652223
Study Section
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
20
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Barthel, Floris P; Johnson, Kevin C; Wesseling, Pieter et al. (2018) Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 36:421-437
Schechter, Lisa M; Creely, David P; Garner, Cherilyn D et al. (2018) Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. MBio 9:

Showing the most recent 10 out of 1156 publications